Research advancement and prospect of clinical application of decoy receptor 3
2008
诱骗受体3(decoy receptor 3,DcR3,又称TR6)是近年新发现的一种可溶性肿瘤坏死因子受体(TNFR)超家族成员,可与Fas,HVEM和DR3竞争结合其相应配体FasL、LIGHT及TLIA,具有阻断细胞凋亡和免疫调节等作用,与恶性肿瘤、自身免疫疾病、移植排斥等密切相关,临床应用前景广泛。
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI